Regula Hits NIST Test: The Only Vendor Recognized Among Top Performers in All Critical Age Estimation Scenarios
9.9.2025 15:30:00 EEST | Business Wire | Press release
For the first time, Regula, a global developer of identity verification (IDV) solutions and forensic devices, has taken part in the National Institute of Standards and Technology (NIST) evaluation for age estimation. This debut could hardly be stronger: Regula achieved the best result in the test, outperforming other vendors. Crucially, Regula’s technology demonstrated consistent accuracy across a wide range of demographics, making it the most universal solution on the market.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250909879354/en/
Regula’s technology estimates age with unmatched precision, gaining top results in the independent NIST test
In addition, Regula ranked among the top three in two of the most critical age assurance scenarios: Challenge 25 and Child Online Safety (ages 13–16).
NIST is a globally respected authority in technology testing and standardization. Its Face Analysis Technology Evaluation (FATE) Age Estimation and Verification benchmark is an open, ongoing program that evaluates how software algorithms estimate age from facial photos. This capability is increasingly important nowadays, as regulators worldwide require reliable age checks to protect minors, enforce access restrictions, and confirm an individual’s age in the absence of official documents.
In this evaluation, NIST confirmed that Regula’s technology estimates age with exceptional accuracy across demographies, consistently outperforming other tested solutions. It came closer to the true age than any other solution tested so far. Regula’s algorithm delivered top results worldwide, with consistent leading accuracy across Europe, East Africa, and East and South Asia.
Beyond overall precision, Regula also excelled in age-restricted scenarios that are directly relevant to regulators and businesses. The Challenge 25 benchmark measures whether individuals who are close to 17 are reliably flagged for additional checks to prevent underage sales. The Child Online Safety benchmark focuses on accurately detecting users aged 13–16 in online environments, while minimizing misclassifications of younger children or adults. Achieving a top-three rank in both scenarios demonstrates that Regula’s technology not only excels in estimating real age but also in protecting minors and helping organizations comply with some of the toughest age-assurance requirements.
The age assurance enhancement will be included in the upcoming Regula Face SDK update. Designed for robust biometric verification, this solution enables thorough facial recognition and comparison, liveness detection, and age verification—an indispensable set of checks to prove that an individual is legitimate and real.
“Reaching the highest accuracy in the NIST evaluation proves the strength of our forensic-driven approach and biometric verification expertise. Just as important, the results confirm that Regula performs consistently across a wide range of real-world conditions, making our solution the most universal on the market. And we’re not stopping here: we are already working to make the technology even more precise and inclusive. Incorporating it into Regula Face SDK will equip our customers with a powerful, reliable way to estimate age in the most challenging environments," says Ihar Kliashchou, Chief Technology Officer at Regula.
Earlier this year, Regula was also recognized as a pioneer in online biometric age assurance for its comprehensive approach that combines advanced document verification with biometric authentication.
For more details on the NIST evaluation of age estimation technologies, see the official report. To learn what challenges and capabilities form today’s age verification solutions, please visit Regula’s website.
About Regula
Regula is a global developer of forensic devices and identity verification solutions. With our 30+ years of experience in forensic research and the most comprehensive library of document templates in the world, we create breakthrough technologies for document and biometric verification. Our hardware and software solutions allow over 1,000 organizations and 80 border control authorities globally to provide top-notch client service without compromising safety, security, or speed. Regula has been repeatedly named a Representative Vendor in the Gartner® Market Guide for Identity Verification.
Learn more at www.regulaforensics.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250909879354/en/
Contacts
Kristina – ks@regula.us
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Textron Aviation Marks 500th Cessna Citation Latitude Rollout22.9.2026 17:19:00 EEST | Press release
Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company, today announced the rollout of the 500th Cessna Citation Latitude business jet from the company’s Wichita, Kansas, manufacturing facility. The production milestone highlights the continued success of the world’s best-selling midsize business jet and recognizes the employees whose craftsmanship and dedication have helped make the Citation Latitude the trusted choice for operators around the world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922867287/en/ Textron Aviation marks 500th Cessna Citation Latitude rollout. (Photo Credit: Textron Aviation) “The rollout of the 500th Citation Latitude is a testament to the employees who build this aircraft with dedication and pride every day,” said Eric Cardinali, senior vice president, Manufacturing. “Behind every aircraft is a team committed to delivering the quality and craftsmanship our customers expect. This milestone
OCP Announces Date of Second Quarter and First Half 2026 Earnings22.9.2026 17:00:00 EEST | Press release
OCP S.A. (“OCP” or the “Company”), a global leader in the fertilizer industry, will release its second quarter and first half 2026 results on Tuesday, September 29, 2026. The results will be available to holders of the Company’s bonds, qualified institutional buyers, securities analysts and market makers on the OCP Intralinks portal from 10:00 a.m. EDT, 2:00 p.m. Morocco (GMT) and 3:00 p.m. London time (GMT+1). OCP senior management will host a conference call to discuss second quarter and first half 2026 results at 11:00 a.m. EDT, 3:00 p.m. Morocco (GMT) and 4:00 p.m. London time (GMT+1) on Tuesday, September 29, 2026, for holders of the Company’s bonds, qualified institutional buyers, securities analysts and market makers. Eligible parties that have not already registered for access to the Intralinks portal may do so by contacting the Investor Relations Department by emailing g.laraki@ocpgroup.ma. About OCP OCP is a global leader in the fertilizer industry, backed by almost a century
Takeda Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research, Led by Late-Breaking Phase 3 Arcotatug Tavatecan (TAK-921) Data, at ESMO 202622.9.2026 16:30:00 EEST | Press release
Takeda(TSE:4502/NYSE:TAK)announced that new data from its oncology pipeline and portfolio will be presented at the European Society for Medical Oncology (ESMO) Congress, taking place October 23-27, 2026, in Madrid, Spain. Key data will include a late-breaking abstract on arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343*) and two presentations on TAK-928 (Innovent R&D code: IBI363*). Clinical and real-world analyses of ALUNBRIG® (brigatinib) and FRUZAQLA® (fruquintinib) will also be shared at the congress. “Takeda’s data at ESMO reflect our commitment to delivering rapid progress for patients living with some of the most prevalent and challenging cancers, including advanced gastric cancer and immunotherapy-resistant and previously untreated non-small cell lung cancer,” said Phuong Khanh (P.K.) Morrow, M.D., Head of the Oncology Therapeutic Area Unit at Takeda. “Our mission is to advance new therapeutic approaches for patients who need more options or who remain underserved by cur
Quaise Energy Selected for Up to $25 Million in U.S. Department of Energy Support to Advance World's First Commercial Superhot Geothermal Power Plant22.9.2026 16:30:00 EEST | Press release
Quaise Energy, a leading developer of utility-scale superhot geothermal energy, today announced that it has been selected by the U.S. Department of Energy (DOE) for up to $25 million in funding under the Next-Generation Geothermal Field Tests and Geothermal Resource Characterization and Confirmation funding opportunity. The support brings the U.S. closer to commercializing superhot Enhanced Geothermal Systems — technology that could unlock firm, clean power from hot rock beneath virtually any geography in the country. The funding will advance Project Obsidian, the world's first commercial superhot geothermal power plant, in Central Oregon. It will support analysis of the drilling, stimulation, and flow results of the first two wells to optimize a third well at the Obsidian site. The three-well configuration is targeting average reservoir temperatures of over 300°C and is designed to demonstrate more than 25 megawatts of gross electric power capacity. The DOE funding will also enable Qu
From CSR to Public Health Impact: How Colgate Bright Smiles, Bright Futures® is Driving Behavior Change for the Next Billion Children and Their Families22.9.2026 16:00:00 EEST | Press release
Colgate-Palmolive, the worldwide leader in oral care, announced a strategic evolution in its flagship oral health education program, Colgate Bright Smiles, Bright Futures® (BSBF), reflecting the Company’s commitment to global public health. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922129016/en/ Launched in 1991, the program has reached over two billion children and their families across more than 100 countries, demonstrating how private-sector commitment designed to support communities, can become a powerful force for public health, driving healthier behaviors and positive outcomes at scale. From health education curriculum and school programming to mobile dental vans and free oral health screenings, BSBF helps children and their families access care, adopt healthier habits, and improve long-term oral health outcomes. “At Colgate-Palmolive, we believe oral health and healthier, brighter futures are inextricably link
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom